| ■ 영문 제목 : Global Betahistine Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2108K201117 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2026년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 133 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (20명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 베타히스틴의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (8mg, 25mg, 기타)와 용도별 시장규모 (뇌혈전증, 뇌색전증, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 베타히스틴 시장 점유율 - 지역별 베타히스틴 시장규모 - 주요지역의 종류별 시장규모 (8mg, 25mg, 기타) - 주요지역의 용도별 시장규모 (뇌혈전증, 뇌색전증, 기타) - 미주의 베타히스틴 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 베타히스틴 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 베타히스틴 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 베타히스틴 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 베타히스틴 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) - 조사의 결과/결론 |
According to this latest study, the 2020 growth of Betahistine will have significant change from previous year. By the most conservative estimates of global Betahistine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Betahistine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Betahistine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
8mg
25mg
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cerebral Thrombosis
Cerebral Embolism
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
TOWA PHARMACEUTICAL CO., LTD
Nichi-Iko Pharmaceutical
Takeda Pharmaceutical Company Limited
EA Pharma Co., Ltd.
Disphar International B.V.
HENNIG ARZNEIMITTEL GmbH & Co. KG
DOC Generici
Ciclum Farma Unipessoal
Mylan
Orion Corporation
1 Scope of the Report 2 Executive Summary 3 Global Betahistine by Company 4 Betahistine by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Betahistine Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Betahistine Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of 8mg Table 3. Major Players of 25mg Table 4. Major Players of Others Table 5. Global Betahistine Sales by Type (2016-2021) & (K Units) Table 6. Global Betahistine Sales Market Share by Type (2016-2021) Table 7. Global Betahistine Revenue by Type (2016-2021) & ($ million) Table 8. Global Betahistine Revenue Market Share by Type (2016-2021) Table 9. Global Betahistine Sale Price by Type (2016-2021) Table 10. Global Betahistine Sales by Application (2016-2021) & (K Units) Table 11. Global Betahistine Sales Market Share by Application (2016-2021) Table 12. Global Betahistine Value by Application (2016-2021) Table 13. Global Betahistine Revenue Market Share by Application (2016-2021) Table 14. Global Betahistine Sale Price by Application (2016-2021) Table 15. Global Betahistine Sales by Company (2019-2021) & (K Units) Table 16. Global Betahistine Sales Market Share by Company (2019-2021) Table 17. Global Betahistine Revenue by Company (2019-2021) ($ Millions) Table 18. Global Betahistine Revenue Market Share by Company (2019-2021) Table 19. Global Betahistine Sale Price by Company (2019-2021) Table 20. Key Manufacturers Betahistine Producing Area Distribution and Sales Area Table 21. Players Betahistine Products Offered Table 22. Betahistine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Betahistine Sales by Region (2016-2021) (K Units) Table 26. Global Betahistine Sales Market Share by Region (2016-2021) Table 27. Global Betahistine Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Betahistine Revenue Market Share by Region (2016-2021) Table 29. Americas Betahistine Sales by Country (2016-2021) & (K Units) Table 30. Americas Betahistine Sales Market Share by Country (2016-2021) Table 31. Americas Betahistine Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Betahistine Revenue Market Share by Country (2016-2021) Table 33. Americas Betahistine Sales by Type (2016-2021) & (K Units) Table 34. Americas Betahistine Sales Market Share by Type (2016-2021) Table 35. Americas Betahistine Sales by Application (2016-2021) & (K Units) Table 36. Americas Betahistine Sales Market Share by Application (2016-2021) Table 37. APAC Betahistine Sales by Region (2016-2021) & (K Units) Table 38. APAC Betahistine Sales Market Share by Region (2016-2021) Table 39. APAC Betahistine Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Betahistine Revenue Market Share by Region (2016-2021) Table 41. APAC Betahistine Sales by Type (2016-2021) & (K Units) Table 42. APAC Betahistine Sales Market Share by Type (2016-2021) Table 43. APAC Betahistine Sales by Application (2016-2021) & (K Units) Table 44. APAC Betahistine Sales Market Share by Application (2016-2021) Table 45. Europe Betahistine Sales by Country (2016-2021) & (K Units) Table 46. Europe Betahistine Sales Market Share by Country (2016-2021) Table 47. Europe Betahistine Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Betahistine Revenue Market Share by Country (2016-2021) Table 49. Europe Betahistine Sales by Type (2016-2021) & (K Units) Table 50. Europe Betahistine Sales Market Share by Type (2016-2021) Table 51. Europe Betahistine Sales by Application (2016-2021) & (K Units) Table 52. Europe Betahistine Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Betahistine Sales by Country (2016-2021) & (K Units) Table 54. Middle East & Africa Betahistine Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Betahistine Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Betahistine Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Betahistine Sales by Type (2016-2021) & (K Units) Table 58. Middle East & Africa Betahistine Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Betahistine Sales by Application (2016-2021) & (K Units) Table 60. Middle East & Africa Betahistine Sales Market Share by Application (2016-2021) Table 61. Global Betahistine Sales Forecast by Type (2021-2026) & (K Units) Table 62. Global Betahistine Sales Market Share Forecast by Type (2021-2026) Table 63. Global Betahistine Revenue Forecast by Type (2021-2026) & ($ Millions) Table 64. Global Betahistine Revenue Market Share Forecast by Type (2021-2026) Table 65. Global Betahistine Sales Forecast by Application (2021-2026) & (K Units) Table 66. Global Betahistine Sales Market Share Forecast by Application (2021-2026) Table 67. Global Betahistine Revenue Forecast by Application (2021-2026) & ($ Millions) Table 68. Global Betahistine Revenue Market Share Forecast by Application (2021-2026) Table 69. TOWA PHARMACEUTICAL CO., LTD Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 70. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Offered Table 71. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 72. TOWA PHARMACEUTICAL CO., LTD Main Business Table 73. TOWA PHARMACEUTICAL CO., LTD Latest Developments Table 74. Nichi-Iko Pharmaceutical Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 75. Nichi-Iko Pharmaceutical Betahistine Product Offered Table 76. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 77. Nichi-Iko Pharmaceutical Main Business Table 78. Nichi-Iko Pharmaceutical Latest Developments Table 79. Takeda Pharmaceutical Company Limited Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 80. Takeda Pharmaceutical Company Limited Betahistine Product Offered Table 81. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 82. Takeda Pharmaceutical Company Limited Main Business Table 83. Takeda Pharmaceutical Company Limited Latest Developments Table 84. EA Pharma Co., Ltd. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 85. EA Pharma Co., Ltd. Betahistine Product Offered Table 86. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 87. EA Pharma Co., Ltd. Main Business Table 88. EA Pharma Co., Ltd. Latest Developments Table 89. Disphar International B.V. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 90. Disphar International B.V. Betahistine Product Offered Table 91. Disphar International B.V. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 92. Disphar International B.V. Main Business Table 93. Disphar International B.V. Latest Developments Table 94. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 95. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Offered Table 96. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 97. HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business Table 98. HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments Table 99. DOC Generici Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 100. DOC Generici Betahistine Product Offered Table 101. DOC Generici Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 102. DOC Generici Main Business Table 103. DOC Generici Latest Developments Table 104. Ciclum Farma Unipessoal Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 105. Ciclum Farma Unipessoal Betahistine Product Offered Table 106. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 107. Ciclum Farma Unipessoal Main Business Table 108. Ciclum Farma Unipessoal Latest Developments Table 109. Mylan Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 110. Mylan Betahistine Product Offered Table 111. Mylan Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 112. Mylan Main Business Table 113. Mylan Latest Developments Table 114. Orion Corporation Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors Table 115. Orion Corporation Betahistine Product Offered Table 116. Orion Corporation Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 117. Orion Corporation Main Business Table 118. Orion Corporation Latest Developments List of Figures Figure 1. Picture of Betahistine Figure 2. Betahistine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Betahistine Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Betahistine Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Betahistine Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of 8mg Figure 10. Product Picture of 25mg Figure 11. Product Picture of Others Figure 12. Global Betahistine Sales Market Share by Type in 2020 Figure 13. Global Betahistine Revenue Market Share by Type (2016-2021) Figure 14. Betahistine Consumed in Cerebral Thrombosis Figure 15. Global Betahistine Market: Cerebral Thrombosis (2016-2021) & (K Units) Figure 16. Betahistine Consumed in Cerebral Embolism Figure 17. Global Betahistine Market: Cerebral Embolism (2016-2021) & (K Units) Figure 18. Betahistine Consumed in Others Figure 19. Global Betahistine Market: Others (2016-2021) & (K Units) Figure 20. Global Betahistine Sales Market Share by Application (2016-2021) Figure 21. Global Betahistine Revenue Market Share by Application in 2020 Figure 22. Global Betahistine Revenue Market by Company in 2020 ($ Million) Figure 23. Global Betahistine Revenue Market Share by Company in 2020 Figure 24. Global Betahistine Sales Market Share by Regions (2016-2021) Figure 25. Global Betahistine Revenue Market Share by Region in 2020 Figure 26. Americas Betahistine Sales 2016-2021 (K Units) Figure 27. Americas Betahistine Revenue 2016-2021 ($ Millions) Figure 28. APAC Betahistine Sales 2016-2021 (K Units) Figure 29. APAC Betahistine Revenue 2016-2021 ($ Millions) Figure 30. Europe Betahistine Sales 2016-2021 (K Units) Figure 31. Europe Betahistine Revenue 2016-2021 ($ Millions) Figure 32. Middle East & Africa Betahistine Sales 2016-2021 (K Units) Figure 33. Middle East & Africa Betahistine Revenue 2016-2021 ($ Millions) Figure 34. Americas Betahistine Sales Market Share by Country in 2020 Figure 35. Americas Betahistine Revenue Market Share by Country in 2020 Figure 36. Americas Betahistine Sales Market Share by Type in 2020 Figure 37. Americas Betahistine Sales Market Share by Application in 2020 Figure 38. United States Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 39. Canada Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 40. Mexico Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 41. Brazil Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 42. APAC Betahistine Sales Market Share by Region in 2020 Figure 43. APAC Betahistine Revenue Market Share by Regions in 2020 Figure 44. APAC Betahistine Sales Market Share by Type in 2020 Figure 45. APAC Betahistine Sales Market Share by Application in 2020 Figure 46. China Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 47. Japan Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 48. Korea Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 49. Southeast Asia Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 50. India Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 51. Australia Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 52. Europe Betahistine Sales Market Share by Country in 2020 Figure 53. Europe Betahistine Revenue Market Share by Country in 2020 Figure 54. Europe Betahistine Sales Market Share by Type in 2020 Figure 55. Europe Betahistine Sales Market Share by Application in 2020 Figure 56. Germany Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 57. France Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 58. UK Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 59. Italy Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 60. Russia Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 61. Middle East & Africa Betahistine Sales Market Share by Country in 2020 Figure 62. Middle East & Africa Betahistine Revenue Market Share by Country in 2020 Figure 63. Middle East & Africa Betahistine Sales Market Share by Type in 2020 Figure 64. Middle East & Africa Betahistine Sales Market Share by Application in 2020 Figure 65. Egypt Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 66. South Africa Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 67. Israel Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 68. Turkey Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 69. GCC Country Betahistine Revenue Growth 2016-2021 ($ Millions) Figure 70. Channels of Distribution Figure 71. Distributors Profiles |
| ※본 조사보고서 [세계의 베타히스틴 시장예측 2021년-2026년] (코드 : LPI-2108K201117) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 베타히스틴 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |